Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

Annals of the Rheumatic Diseases, 2009 - ard.bmj.com
Objectives: To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

[引用][C] Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

R CERVERA, MA KHAMASHTA… - Annals of the …, 2009 - pascal-francis.inist.fr
Author CERVERA, R; KHAMASHTA, M. A; BELLISAI, F; MERONI, P. L; DERKSEN, RHW M;
DE GROOT, P. G; GROMNICA-LHLE, E; BALEVA, M; MOSCA, M; BOMBARDIERI, S; …

[引用][C] MORBIDITY AND MORTALITY IN THE ANTIPHOSPHOLIPID SYNDROME DURING A 5-YEAR PERIOD: A MULTICENTER PROSPECTIVE STUDY OF 1,000 …

R Cervera, M Khamashta, Y Shoenfeld… - ANNALS OF THE …, 2009 - iris.unibs.it

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients Research output: Contribution to …

R Cervera, MA Khamashta, Y Shoenfeld, MT Camps… - comm.ku.dk
OBJECTIVES: To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

R Cervera, MA Khamashta, Y Shoenfeld… - ANNALS OF THE …, 2009 - air.unimi.it
Objectives: To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

R Cervera, M Khamashta, Y Shoenfeld… - ANNALS OF THE …, 2009 - arpi.unipi.it
OBJECTIVES: To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients.

R Cervera, MA Khamashta, Y Shoenfeld… - Annals of the …, 2008 - europepmc.org
Objectives To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

R Cervera, MA Khamashta… - Annals of the …, 2009 - pubmed.ncbi.nlm.nih.gov
Objectives To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

R Cervera, F Houssiau, E Kiss - Annals of the Rheumatic …, 2009 - dial.uclouvain.be
Objectives: To identify the main causes of morbidity and mortality in patients with
antiphospholipid syndrome (APS) during a 5-year period and to determine clinical and …

Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a multicentre prospective study of 1000 patients

R Cervera, MA Khamashta, Y Shoenfeld… - Annals of the …, 2009 - research.regionh.dk
Morbidity and mortality in the antiphospholipid syndrome during a 5-year period: a
multicentre prospective study of 1000 patients — The Capital Region of Denmark's …